bioMérieux S.A. (EPA:BIM)
90.35
+0.20 (0.22%)
Apr 21, 2026, 5:04 PM CET
bioMérieux Market Cap
bioMérieux has a market cap or net worth of €10.63 billion as of April 21, 2026. Its market cap has decreased by -21.46% in one year.
Market Cap
10.63B
Enterprise Value
10.53B
Revenue
4.07B
Ranking
n/a
PE Ratio
26.99
Stock Price
€90.35
Market Cap Chart
Since July 7, 2004, bioMérieux's market cap has increased from 1.18B to 10.63B, an increase of 798.40%. That is a compound annual growth rate of 10.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 20, 2026 | 10.63B | -18.35% |
| Dec 31, 2025 | 13.02B | 6.63% |
| Dec 31, 2024 | 12.21B | 2.78% |
| Dec 29, 2023 | 11.88B | 2.52% |
| Dec 30, 2022 | 11.59B | -21.58% |
| Dec 31, 2021 | 14.78B | 8.25% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EssilorLuxottica Société anonyme | 99.55B |
| Sanofi | 99.04B |
| Sartorius Stedim Biotech | 18.36B |
| Ipsen | 13.28B |
| Eurofins Scientific SE | 12.29B |
| ABIVAX Société Anonyme | 8.29B |
| Virbac | 3.21B |
| emeis Société anonyme | 2.26B |